Equities

Calumet Inc

CLMT:NSQ

Calumet Inc

Actions
Basic MaterialsChemicals
  • Price (USD)18.03
  • Today's Change-0.21 / -1.15%
  • Shares traded1.32m
  • 1 Year change-7.44%
  • Beta1.9303
Data delayed at least 15 minutes, as of Sep 19 2024 21:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments7.903538
Total Receivables, Net286268253
Total Inventory439498327
Prepaid expenses521915
Other current assets, total9.60----
Total current assets795820633
Property, plant & equipment, net1,6211,5901,107
Goodwill, net173173173
Intangibles, net293646
Long term investments------
Note receivable - long term------
Other long term assets13412385
Total assets2,7512,7422,128
LIABILITIES
Accounts payable322442301
Accrued expenses225198187
Notes payable/short-term debt000
Current portion long-term debt/capital leases3334197.40
Other current liabilities, total233292405
Total current liabilities1,1131,352900
Total long term debt1,8301,6171,498
Total debt2,1632,0371,505
Deferred income tax------
Minority interest246250--
Other liabilities, total5460116
Total liabilities3,2423,2802,513
SHAREHOLDERS EQUITY
Common stock(484)(530)(379)
Additional paid-in capital------
Retained earnings (accumulated deficit)------
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total(7.2)(8.3)(10)
Total equity(490)(538)(385)
Total liabilities & shareholders' equity2,7512,7422,128
Total common shares outstanding807979
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.